CVS to pay almost $40 million for overbilling Tricare and other federal insurers for insulin pens

CVS to pay almost $40 million for overbilling Tricare and other federal insurers for insulin pens

CVS will pay for dispensing and billing health care plans including Tricare for more insulin than was prescribed, according to a lawsuit settlement.

CVS Health to pay $37.76 million over insulin pen overbilling allegations

NEW YORK — CVS Health has agreed to pay $37.76 million to resolve allegations that it over-dispensed insulin pens and improperly billed federal health care programs. The settlement, announced by the Department of Justice, covers a 10-year period from 2010 to 2020 and addresses violations of the False Claims Act involving Medicare, Medicaid, TRICARE, and the Federal Employees Health Benefits Program.Federal authorities alleged CVS pharmacies repe…